ACE-inhibitor induced angioedema masked by nephrotic syndrome

Abstract

Angiotensin-converting enzyme (ACE) inhibitors are the leading cause of drug-induced angioedema in the United States because these drugs are widely prescribed for several common medical disorders. Angiotensin-converting enzyme inhibitors cause angioedema in 0.1 to 0.7 percent of recipients. When prescribing ACE-inhibitors to patients, angioedema should always be considered as a potential adverse reaction during treatment.

Keywords

• angioedema
• angiotensin-converting enzyme inhibitor
• nephrotic syndrome